Psychedelics as mental-health therapy
Clinical trials suggest guided psilocybin sessions can durably relieve depression, addiction, and end-of-life anxiety. A single profound experience, properly framed, can shift entrenched patterns.
How to Change Your Mind
6 ideas
The suppression and revival of research
Promising 1950s-60s psychedelic research was shut down amid cultural backlash, then quietly revived decades later at institutions like Johns Hopkins. The history shows science bending to politics and then recovering.
Default Mode Network as Ego's Seat
The default mode network is a set of linked brain regions that is active during self-reflection, mind-wandering, and autobiographical thinking, and functions as a top-down 'orchestra conductor' that maintains the sense of a separate self. Psilocybin and LSD sharply reduce activity in this network. That reduction correlates with ego dissolution and lets normally segregated brain regions communicate directly, which may be why these drugs can produce novel perceptions and insights.
Set and Setting Determine the Experience
A psychedelic experience is shaped less by the molecule than by 'set', the user's mindset, intentions, and expectations, and by 'setting', the physical and social environment and the guide present. The same dose can produce terror or transcendence depending on these conditions. That is why 1950s researchers who expected psychosis tended to observe it, while guided and supportive sessions produced healing.
Cancer Patients Losing Fear of Death
In psilocybin trials at NYU and Johns Hopkins, people with terminal or serious cancer received a single guided high-dose session, and most showed large, lasting drops in anxiety and depression about dying. One participant, Patrick Mettes, dying of bile-duct cancer, described an overwhelming experience of love. Afterward he faced his death with equanimity until he died about a year and a half later.
The Mystical Experience Itself Is Therapeutic
In psilocybin trials for addiction, depression, and end-of-life distress, how intensely a subject rated their 'mystical-type' experience predicted how much they improved. This suggests the benefit comes from the subjective experience, not simply from the drug's chemistry. The experience appears to work like shaking a snow globe: it loosens rigid, self-reinforcing patterns of thought, such as rumination or compulsive craving, so the person can form new perspectives.